1 / 3

Asia-Pacific osteoarthritis therapeutics market

Asia-Pacific Osteoarthritis Therapeutics Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

Download Presentation

Asia-Pacific osteoarthritis therapeutics market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Asia-Pacific Osteoarthritis Therapeutics Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027 Request a Free Sample @ https://www.omrglobal.com/request-sample/asia-pacific- osteoarthritis-therapeutics-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Asia-Pacific osteoarthritis therapeutics market is estimated to grow at a CAGR of 8.8% during the forecast period. Rising prevalence of osteoarthritis is the major factor leveraging market growth. As per the Ministry of Health and Family Welfare (MoHFW), in India, osteoarthritis is the most frequent joint disease with a prevalence of 22% to 39% and is the second most common rheumatologic problem. Osteoarthritis is more common in women compared to men. Approximately 45% of women more than aged 65 years have symptoms while 70% of those more than aged 65 years signifies radiological evidence of osteoarthritis. To @ https://www.omrglobal.com/request-sample/asia-pacific-osteoarthritis-therapeutics- market learn more about this report request a free sample copy Analgesics are used for osteoarthritis pain treatment; however, they don’t treat inflammation. This drug class works by stopping signals in the body that creates pain. Instances of analgesics include Acetaminophen (Tylenol) and Duloxetine (Cymbalta). Acetaminophen (Tylenol) is an over the counter (OTC) analgesic that can be administered orally as a tablet, gel capsule, or liquid concentration. Another class of drugs is known as nonsteroidal anti-inflammatory drugs (NSAIDs) that are also used for the treatment of pain. As compared to analgesics, NSAIDs also support the prevention of joint damage and painful inflammation. These drugs are regarded as a suitable choice to treat osteoarthritis patients as they are non-sedating and effective. Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/asia- pacific-osteoarthritis-therapeutics-market Asia-Pacific Osteoarthritis Therapeutics Market-Segmentation By Anatomy Knee Ankle Hip Hand Spine By Drug Type Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Viscosupplementation Agents Corticosteroids Analgesics Asia-Pacific Osteoarthritis Therapeutics Market– Segment by Country China

  3. Japan India Company Profiles Cipla Ltd. Daiichi Sankyo Co., Ltd. Dr. Reddy's Laboratories GlaxoSmithKline plc Hanmi Pharmaceutical Co., Ltd. Lupin Ltd. Pfizer Inc. Sanofi S.A. Sun Pharmaceutical Industries Ltd. Virchow Biotech Private Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-osteoarthritis-therapeutics- market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related